COV 5.41% 35.0¢ cleo diagnostics ltd

Ann: Cleo Commences US Regulatory Process with FDA, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,156 Posts.
    lightbulb Created with Sketch. 1832

    What FDA wants to see:

    https://hotcopper.com.au/data/attachments/6271/6271665-fce0ccdb8b2af99ea91710ccd4970732.jpg

    What Cleo has already proven and announced on 29/5:

    https://hotcopper.com.au/data/attachments/6271/6271668-3b7d85a46ae3a36ff86a0321781ea3e2.jpg

    My guess is that it is a good guide on where the next set of trials will go.

    DYOR. No advice.
 
watchlist Created with Sketch. Add COV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.